As of 2024-09-10, the EV/EBITDA ratio of Arena Pharmaceuticals Inc (ARNA) is -10.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ARNA's latest enterprise value is 5,982.02 mil USD. ARNA's TTM EBITDA according to its financial statements is -545.06 mil USD. Dividing these 2 quantities gives us the above ARNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.4x - 20.2x | 17.1x |
| Forward P/E multiples | 20.7x - 24.4x | 22.7x |
| Fair Price | (180.01) - (175.59) | (172.94) |
| Upside | -280.0% - -275.6% | -273.0% |
| Date | EV/EBITDA |